Plate IV.233 · Publications

Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation

Article in Frontiers in Immunology, 28 July 2022.

Open accessResearch area: Lung, Epithelial Cells

Authors

  1. Kevin Baßler
  2. Wataru Fujii
  3. Theodore S. Kapellos
  4. Erika Dudkin
  5. Nico Reusch
  6. Ari Horne
  7. Benedikt Reiz
  8. Malte D. Luecken
  9. Collins Osei-Sarpong
  10. Stefanie Warnat-Herresthal
  11. Lorenzo Bonaguro
  12. Jonas Schulte-Schrepping
  13. Allon Wagner
  14. Patrick Günther
  15. Carmen Pizarro
  16. Tina Schreiber
  17. Rainer Knoll
  18. Lisa Holsten
  19. Charlotte Kröger
  20. Elena De Domenico
  21. Matthias Becker
  22. Kristian Händler
  23. Christian T. Wohnhaas
  24. Florian Baumgartner
  25. Meike Köhler
  26. Heidi Theis
  27. Michael Kraut
  28. Marc H. Wadsworth
  29. Travis K. Hughes
  30. Humberto J. Ferreira
  31. Emily Hinkley
  32. Ines H. Kaltheuner
  33. Matthias Geyer
  34. Christoph Thiele
  35. Alex K. Shalek
  36. Andreas Feißt
  37. Daniel Thomas
  38. Henning Dickten
  39. Marc Beyer
  40. Patrick Baum
  41. Nir Yosef
  42. Anna C. Aschenbrenner
  43. Thomas Ulas
  44. Jan Hasenauer
  45. Fabian J. Theis
  46. Dirk Skowasch
  47. Joachim L. Schultze

Abstract

Despite its high prevalence, the cellular and molecular mechanisms of chronic obstructive pulmonary disease (COPD) are far from being understood. Here, we determine disease-related changes in cellular and molecular compositions within the alveolar space and peripheral blood of a cohort of COPD patients and controls. Myeloid cells were the largest cellular compartment in the alveolar space with invading monocytes and proliferating macrophages elevated in COPD. Modeling cell-to-cell communication, signaling pathway usage, and transcription factor binding predicts TGF-β1 to be a major upstream regulator of transcriptional changes in alveolar macrophages of COPD patients. Functionally, macrophages in COPD showed reduced antigen presentation capacity, accumulation of cholesteryl ester, reduced cellular chemotaxis, and mitochondrial dysfunction, reminiscent of impaired immune activation.

Cite

@article{bassler2022alveolar,
  title = {{Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation}},
  author = {Baßler, Kevin and Fujii, Wataru and Kapellos, Theodore S. and Dudkin, Erika and Reusch, Nico and Horne, Ari and Reiz, Benedikt and Luecken, Malte D. and Osei-Sarpong, Collins and Warnat-Herresthal, Stefanie and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and Wagner, Allon and Günther, Patrick and Pizarro, Carmen and Schreiber, Tina and Knoll, Rainer and Holsten, Lisa and Kröger, Charlotte and De Domenico, Elena and Becker, Matthias and Händler, Kristian and Wohnhaas, Christian T. and Baumgartner, Florian and Köhler, Meike and Theis, Heidi and Kraut, Michael and Wadsworth, Marc H. and Hughes, Travis K. and Ferreira, Humberto J. and Hinkley, Emily and Kaltheuner, Ines H. and Geyer, Matthias and Thiele, Christoph and Shalek, Alex K. and Feißt, Andreas and Thomas, Daniel and Dickten, Henning and Beyer, Marc and Baum, Patrick and Yosef, Nir and Aschenbrenner, Anna C. and Ulas, Thomas and Hasenauer, Jan and Theis, Fabian J. and Skowasch, Dirk and Schultze, Joachim L.},
  journal = {Frontiers in Immunology},
  publisher = {Frontiers Media SA},
  year = {2022},
  month = jul,
  doi = {10.3389/fimmu.2022.917232},
  url = {https://doi.org/10.3389/fimmu.2022.917232},
  pmid = {35979364},
  pmcid = {PMC9377018}
}
.bib file